Drug · DIN 02220172
LOVASTATIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 15, 2021; first marketed March 27, 1997.
- Drug Identification Number (DIN)
- 02220172
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lovastatin C10AA02
- Class
- Human
- Record last updated
- August 15, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LOVASTATIN | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 26, 2021: NOC 25308New Drug Submission (NDS) · Change in product ownership
- March 26, 1997: NOC 3919New Drug Submission (NDS)
Other DINs named LOVASTATIN
- DIN 02220180 · Marketed
- DIN 02344335 · Cancelled Pre Market
- DIN 02344343 · Cancelled Pre Market
- DIN 02353229 · Cancelled Post Market
- DIN 02353237 · Cancelled Post Market